Latest Breaking News On - Antibody drug conjugate - Page 5 : comparemela.com

Endometrial Cancer: Elahare and Keytruda Lead the ADC and ICI Path

Elahere and Keytruda are leading the path for combination therapy of ADC and ICI for endometrial cancer.

United statesKeytruda pemrolizumabElahere mirvetuximab soravtansine gynxJasminemay barcelonAmerican association for cancer researchMerck coAmerican associationCancer researchTargeted therapiesOvarian cancer combinationDrug conjugatesEndometrial cancerHematology analystMirvetuximab soravtansine gynxEndometrial cancerAntibody drug conjugate

Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate

Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Eric vivierChief scientific officerInnate pharmaAntibody drug conjugate

Innate Pharma SA: Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate

Innate Pharma SA: Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesEric vivierHenry wheelerDennis riedlArthur rouillAmerican association for cancer researchCompany annual report on formExchange commissionFrench financial markets authorityAntibody drug conjugateEuronext parisAmerican associationCancer researchAnnual meetingEnfortumab vedotinChief scientific officer

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2024 show promising initial data for patients with lymphoma, gastric or gastroesophageal junction cancers, and specific molecularly selected tumors.

United statesKlus pharmaJordi rodonTimothy yapMerck coDevelopment agreementAndrew sabin family fellowship programAmerican association for cancer researchUniversity of texas md anderson cancer centerExperimental therapeutics clinical trials networkBristol myers squibb companyNational cancer institute therapy evaluation programNational cancer instituteAstrazeneca pharmaceuticalsNational institutes of healthManderson cancer

Adcentrx Therapeutics Appoints Meng Jiang as Chief Financial Officer

/PRNewswire/ Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other.

Meng jiangNew yorkUnited statesHui liFu weiWellesley collegeBusiness development asiaInvestment bankManagement committee memberAdcentrx therapeuticsAntibody drug conjugateChief financial officerSenior managing directorManagement committeeFar east horizonChief executive officer